FDA Annual Registration Renewal: Deadlines, Fees, and What Happens If You Miss the Window

FDA Annual Registration Renewal: What Every Medical Device Company Needs to Know Before December 31

Every year, without exception, medical device establishments must renew their FDA registration between October 1 and December 31. It sounds straightforward. Yet year after year, startups lose their registration status, get flagged during inspections, or discover their products are legally considered misbranded — all because they missed a window that closes on New Year's Eve.

If you are a founder scaling your first device company, a VP of Quality juggling a dozen compliance priorities, or a regulatory affairs professional supporting multiple business units, this is one deadline you cannot afford to treat casually. Here is exactly what you need to know.

The Regulatory Basis: 21 CFR Part 807

FDA establishment registration and device listing requirements are governed primarily by 21 CFR Part 807, which implements Section 510 of the Federal Food, Drug, and Cosmetic Act (FD&C Act). Under this framework, domestic device establishments — and foreign establishments whose devices are imported or offered for import into the United States — must register annually with FDA.

The annual renewal obligation is not optional and is not tied to whether your establishment had any manufacturing activity during the year. If you are a registered establishment, you must renew. Full stop.

FDA also references its guidance document 'Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices' to clarify the scope of who must register, what constitutes a registerable establishment, and how device listings must be maintained alongside registration.

The Registration Window: October 1 to December 31

FDA opens the annual renewal window on October 1 of each year. All establishments must complete renewal by December 31 at midnight. This three-month window is intentional — it gives companies adequate time to log into the FDA Unified Registration and Listing System (FURLS), confirm establishment information, update device listings if needed, and pay the required user fee.

Do not wait until December. System outages, payment processing delays, and internal approval bottlenecks are real and have derailed renewals for otherwise diligent companies. Best practice is to initiate renewal no later than mid-October.

FY2025 Registration Fees: What You Will Pay

Registration is not free. Under the Medical Device User Fee Amendments (MDUFA), FDA charges an annual establishment registration fee. For Fiscal Year 2025, the standard fee is $7,653 per establishment. This figure is adjusted annually, so always verify the current fee on FDA's official user fee page before initiating payment.

There is a reduced fee available for small businesses as defined under 21 CFR 807.3(n) — generally those with gross receipts or sales of $100 million or less. If your company qualifies, you must apply separately for small business status. The reduced fee is not applied automatically.

Key points about fees:

• Payment must be received by FDA before renewal is considered complete.
• Foreign establishments pay the same fee as domestic ones.
• FDA does not issue refunds if registration lapses due to non-payment.
• Contract manufacturers and specification developers each have their own registration obligations and fees.

What Happens If You Miss the Deadline

This is where companies get into serious trouble. Under 21 CFR 807.20 and the FD&C Act, a device manufactured at or distributed from an establishment that is not properly registered is deemed misbranded under Section 502(o) of the Act. Misbranded devices are subject to regulatory action, including seizure, injunction, and civil monetary penalties.

Practically speaking, here is what a lapsed registration can trigger:

• Import alerts and detention: Foreign establishments with lapsed registration risk having their devices detained at the US border under FDA's Detention Without Physical Examination (DWPE) authority.
• Distribution holds: Domestic distributors and partners may refuse to ship or sell product from an unregistered establishment once they become aware of the lapse.
• FDA inspection complications: A lapsed registration discovered during a 483 inspection or warning letter review compounds your regulatory risk significantly.
• Customer and investor red flags: Sophisticated hospital systems, group purchasing organizations, and institutional investors conduct regulatory due diligence. An unregistered establishment is a material finding.

There is no formal grace period. FDA does not send reminders. The obligation to renew is yours.

Practical Steps to Protect Your Registration

Build a recurring internal process around this deadline rather than relying on memory or a single person's awareness. Recommended actions include:

• Set calendar reminders for October 1 and November 1 across your quality and regulatory teams.
• Confirm your FURLS account credentials are current well before October — account recovery delays are common.
• Audit your device listings at the same time as registration renewal; outdated listings create separate compliance exposure under 21 CFR 807.26.
• If you have added, discontinued, or modified devices during the year, update your listings concurrently with renewal.
• Confirm your small business status application is on file if you intend to pay the reduced fee.

A Note on Foreign Establishments and US Agents

Foreign device manufacturers exporting to the US must also register annually and must designate a US Agent as required under 21 CFR 807.40. The US Agent serves as FDA's primary point of contact for that establishment. If your US Agent has changed or their contact information is outdated, update it during renewal. An unreachable US Agent is itself a compliance vulnerability.

Do Not Let an Administrative Deadline Create a Regulatory Crisis

Annual registration renewal is one of the most straightforward compliance obligations in FDA's device framework — but its consequences when missed are anything but minor. Treat it as a business-critical process, not a back-office task.

At ADB Consulting and CRO Inc., we work with medical device startups and established manufacturers to build regulatory infrastructure that prevents exactly these kinds of compliance gaps. Whether you need help auditing your current registration status, navigating FURLS, or building a sustainable annual compliance calendar, our team is ready to support you.

Book a free discovery call with Andre Butler and the ADB Consulting team at adbccro.com. Let us make sure your registration is current, your listings are accurate, and your compliance program is built to scale.

Related reading: our FDA establishment registration and listing service covers this in more depth.